Interview with Colin Edwards, General Manager, Boehringer Ingelheim Ireland
Dr. Edwards, you have been both a lecturer and a researcher. What made you ‘come over to the dark side’ and become a manager? I do not find it to…
Address: The Hyde Building,
4th Floor,
The Park, Carrickmines. Dublin 18 ,Ireland
Tel: 353 1 291-3904
Web: http://www.boehringer-ingelheim.ie/
Boehringer Ingelheim is a global group of companies, one of the world’s 20 leading pharmaceutical corporations.
Our mission is to improve the health and well being of people and animals through being a part of an independent, innovative, research and development driven company.
We have an excellent reputation for providing effective products for the treatment of respiratory disease, cardiovascular disease, HIV, Parkinson’s disease, thromboembolic disease, cerebrovascular disease and depression.
Dr. Edwards, you have been both a lecturer and a researcher. What made you ‘come over to the dark side’ and become a manager? I do not find it to…
Dr. Leisha Daly, Janssen Ireland country director and president of the Irish Pharmaceutical Healthcare Association (IPHA) discusses her presidency and the conclusion of a four-year agreement between IPHA and the…
With nearly €4 billion of capital investment in large molecule manufacturing underway, Ireland’s strategy to become a premier destination for biologics FDI has proven to be successful, according to BioPharmaChem Ireland…
Known as “Ireland’s university of Enterprise,” Dublin City University’s research and educational philosophy is very much informed by the institution’s strong partnerships and collaborations with the private sector. Professor Brian…
Founded in 2011, APC has grown to be the largest process development company in Ireland. It is the largest employer of PhD Chemical Engineers nationally, is partners with the largest pharma and…
After a number of years of difficulty post-2008 and the euro-debt crisis, Ireland’s pharma manufacturing industry and economy in general is now firmly on the up. The local Irish pharma…
FDI into Irish pharma has almost exclusively targeted in biologics production over the last few years, largely due to Ireland’s skilled workforce of bioprocessing technicians. NIBRT director Dominic Carolan discusses…
The VP of Pfizer’s external supply operating unit talks about his company’s growing presence in Ireland over the last four decades, culminating in the creation of the world’s largest biopharmaceutical…
The managing partner, along with two other partners from ByrneWallace discuss the current legal framework in Ireland for small to mid-size companies operating in the pharmaceutical sector. Can you please…
“If you look at the cuts in the public sector, the science budget has been relatively lightly touched. This sends a signal at a very high level that science, the…
Cormac Callaghan, founder and managing director of Primecore, a portfolio and program management consultancy based in Dublin and Cambridge, Massachusetts, has managed large-scale change programs for the pharmaceutical industry for…
What makes Ireland attractive for FDI? As the former general manager of Genzyme’s Waterford site, Pat O’Sullivan explains that a longstanding 12.5% corporate tax rate (that isn’t going anywhere)…
Lilly set up in Ireland three decades ago by purchasing a farm. In its early days, the operation produced intermediaries for small-molecule drugs. Nearby, Pfizer was manufacturing citric acid for…
See our Cookie Privacy Policy Here